Moderate novel coronavirus infection
Conditions
Interventions
experimental group:Basic treatment add Lianhua cough clearing tablets
control group:Basic treatment add placebo control
Sponsors
Qilu Hospital of Shandong University (Qingdao)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.The diagnostic criteria are consistent with the diagnostic criteria for moderate COVID-19 infection. 2.Over 18 years of age (including 18 years of age), male or female. 3.Have cough symptoms. 4.Written informed consent is signed voluntarily by the patients participating in this clinical trial before enrollment.
Exclusion criteria
Exclusion criteria: 1.Patients who have other respiratory diseases (e.g., chronic obstructive pulmonary disease, tumors, tuberculosis) or whose cough or phlegm symptoms are determined by the investigator to be caused by other diseases (e.g., pneumoconiosis, pulmonary abscess, bronchiectasis, cough variant asthma, eosinophilic bronchitis, or upper airway cough syndrome) or whose cough symptoms are caused by medications. 2.Patients with serious primary diseases of the heart, brain, lung, liver, kidney and hematopoietic systems, as well as mental diseases. 3.Allergic constitution (allergic to more than 2 types of substances), or allergic to the composition of this preparation. 4.Alanine aminotransferase (ALT), aspartate aminotransferase (AST) >5× upper limit of normal (ULN). 5.Pregnant, lactating and pregnant women. 6.Participants in other drug clinical trials within the past 1 month. 7.A suspected or existing history of alcohol or drug abuse, or other conditions or conditions that, in the investigator's judgment, reduce or complicate enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of disappearance of cough symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement rate of CT examination;Pulse oxygen monitoring(In the state of inhaled air);Proportion of turning severe or critical; | — |
Countries
China
Contacts
Public ContactDing Meiling
Qilu Hospital of Shandong University (Qingdao)
Outcome results
None listed